Ppd testing in patients starting infliximab for treatment of inflammatory bowel disease

被引：0
|
作者：
Minor, Melissa
Ghimire, Sanjay
Singh, Surya
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] D2Hawkeye Inc, Waltham, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷
关键词：
D O I：
10.14309/00000434-200809001-01042
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1042
引用
收藏
页码：S408 / S408
页数：1
相关论文
共 50 条
  • [21] Infliximab: A Review of Its Use in the Treatment of Inflammatory Bowel Disease
    Marzo, Manuela
    Felice, Carla
    Rapaccini, Gian Lodovico
    Guidi, Luisa
    Armuzzi, Alessandro
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 15 - 29
  • [22] Adherence to Infliximab Treatment in a Pediatric Inflammatory Bowel Disease Cohort
    Vitale, David S.
    Greenley, Rachel N.
    Lerner, Diana G.
    Mavis, Alisha M.
    Werlin, Steven L.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2015, 61 (04): : 408 - 410
  • [23] Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease
    van Casteren-Messidoro, Chiara
    Prins, Gerrie
    van Tilburg, Antonie
    Zelinkova, Zuzana
    Schouten, Joeffrey
    de Man, Rob
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (05): : 630 - 631
  • [24] Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease
    Sandborn, WJ
    Loftus, EV
    GUT, 2004, 53 (06) : 780 - 782
  • [25] Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients
    Detrez, Iris
    Thomas, Debby
    Van Steen, Kristel
    Ballet, Vera
    Peeters, Miet
    Hoylaerts, Marc F.
    Van Assche, Gert
    Vermeire, Severine
    Ferrante, Marc
    Gils, Ann
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2020, 54 (09) : 819 - 825
  • [26] Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
    Amy Hemperly
    Niels Vande Casteele
    Clinical Pharmacokinetics, 2018, 57 : 929 - 942
  • [27] Usefulness of therapeutic monitoring of infliximab in the treatment of inflammatory bowel disease
    Quera, Rodrigo
    Moreno, Mauricio
    Simian, Daniela
    Ibanez, Patricio
    Lubascher, Jaime
    Figueroa, Carolina
    Flores, Lilian
    Kronberg, Udo
    Pizarro, Gonzalo
    Fluxa, Daniela
    REVISTA MEDICA DE CHILE, 2018, 146 (11) : 1241 - 1251
  • [28] Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease
    Regueiro, M
    Valentine, J
    Plevy, S
    Fleisher, MR
    Lichtenstein, GR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (08): : 1821 - 1826
  • [29] INFLIXIMAB IN THE TREATMENT OF 171 PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A CANADIAN TERTIARY CENTER
    Sternzus, R.
    Leibovitch, S.
    Noble, A.
    Deslandres, C.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E101 - E101
  • [30] Efficacy and Safety of Infliximab in Older Inflammatory Bowel Disease Patients
    Lindenmeyer, Christina
    Moleski, Stephanie
    Whitsett, Maureen
    Kozuch, Patricia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S509 - S509
12345